Estimaciones de analistas de Wall Street para Ekso Bionics Holdings, Inc. (EKSO): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-07-27 | $-0.06 | ||
| 2026-04-28 | $-2.04 | $-0.03 | -6700.0% |
| 2026-02-23 | $-1.56 | $-0.08 | -1850.0% |
| 2025-10-28 | $-0.54 | $-0.99 | +45.5% |
| 2025-07-28 | $-1.24 | $-1.20 | -3.3% |
| 2025-05-05 | $-1.80 | $-1.65 | -9.1% |
| 2025-03-03 | $-2.10 | $-0.07 | -2900.0% |
| 2024-10-28 | $-1.50 | $-1.20 | -25.0% |
Ratios de valoración
| Precio / Valor contable | 9.87 |
| EV / EBITDA | -2.91 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $14.2M | $7.4M | $11.3M | $13.9M | $8.9M | $11.2M | $12.9M | $18.3M | $17.9M | $12.8M |
| Coste de Ventas | $11.3M | $5.3M | $7.0M | $7.2M | $3.8M | $4.5M | $6.7M | $9.2M | $8.4M | $6.0M |
| Beneficio Bruto | $2.9M | $2.1M | $4.3M | $6.8M | $5.1M | $6.7M | $6.2M | $9.1M | $9.5M | $6.8M |
| I+D | $8.9M | $9.5M | $5.8M | $4.6M | $2.5M | $2.7M | $3.6M | $5.0M | $3.9M | $3.0M |
| Generales y Administrativos | $21.9M | $23.9M | $25.5M | $18.8M | $15.5M | $17.8M | $18.1M | $19.2M | $16.1M | $17.1M |
| Gastos Operativos | $30.7M | $33.4M | $31.4M | $23.4M | $17.9M | $20.6M | $21.8M | $24.2M | $20.0M | $20.2M |
| Beneficio Operativo | -$27.6M | -$31.6M | -$27.0M | -$16.6M | -$12.9M | -$13.8M | -$15.6M | -$15.1M | -$10.5M | -$13.3M |
| EBITDA | -$21.6M | -$26.7M | -$24.9M | -$11.1M | -$15.1M | -$9.1M | -$14.0M | -$13.2M | -$9.5M | -$9.8M |
| Gastos por Intereses | $16000 | $648000 | $600000 | $384000 | $139000 | $113000 | $156000 | $302000 | $269000 | $309000 |
| Beneficio Antes de Impuestos | -$23.5M | -$29.1M | -$27.0M | -$12.1M | -$15.8M | -$9.8M | -$15.1M | -$15.2M | -$11.3M | -$11.7M |
| Impuestos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$23.5M | -$29.1M | -$27.0M | -$12.1M | -$15.8M | -$9.8M | -$15.1M | -$15.2M | -$11.3M | -$11.7M |
| BPA | $-419.75 | $-184.01 | $-99.19 | $-37.96 | $-33.13 | $-12.01 | $-17.45 | $-16.44 | $-8.43 | $-4.91 |
| BPA Diluido | $-419.75 | $-184.01 | $-99.19 | $-37.96 | $-33.13 | $-13.20 | $-17.45 | $-16.44 | $-8.43 | $-4.91 |
| Acciones en Circulación (Diluidas) | $80559 | $158262 | $272128 | $319604 | $477599 | $817933 | $864133 | $924466 | $1.3M | $2.4M |
Precio
| Precio | $15.90 |
| Capitalización | $39M |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: AEMD · ALUR · ANL · AYTU · CODX · ERNA · GOVX
Explorar sector: Technology · Information Technology Services
Más secciones de EKSO: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones